Sleeping hearts: the role of the heart in sleeping sickness (human African trypanosomiasis).

To estimate the frequency and evolution of heart involvement in human African trypanosomiasis (HAT) using electrocardiogram (ECG) findings; to describe these findings and to assess the frequency and clinical relevance of symptoms and signs before and after treatment.
In a prospective cohort study ECG findings, signs and symptoms consistent with heart failure and cardiac laboratory parameters were studied at baseline, 2 days after the end of treatment and 3 months later.
Major ECG alterations were significantly more frequent in HAT patients than in healthy controls (71%vs. 18%; P < 0.001); 31% were low voltage changes, 34% were repolarization changes. ECG signs of necrosis and conduction problems were rare. Symptoms consistent with heart failure such as exertional dyspnoea (19%vs. 1.7%; P = 0.002) or palpitations (18%vs. 5%; P = 0.28) occurred more frequently in patients than in controls. The median NT-proBNP was significantly higher in HAT patients than in controls (85.2 vs. 28 pg/ml; P < 0.001). Troponin levels were normal. At the end of treatment repolarization changes appeared or worsened in 33.4%. Such changes improved or disappeared at follow-up in 33.1% of the patients.
Cardiac involvement documented by ECG alterations is common in HAT patients, but cardiopathy rarely causes severe congestive heart failure and subsides after treatment. ECG alterations immediately after treatment and their improvement 3 months later may be the result of a treatment-induced inflammatory reaction.
AuthorsJohannes A Blum, Christian Burri, Christoph Hatz, Leon Kazumba, Patrick Mangoni, Michael J Zellweger
JournalTropical medicine & international health : TM & IH (Trop Med Int Health) Vol. 12 Issue 12 Pg. 1422-32 (Dec 2007) ISSN: 1365-3156 [Electronic] England
PMID18076548 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Trypanocidal Agents
  • Melarsoprol
  • Eflornithine
  • Adult
  • Animals
  • Eflornithine (therapeutic use)
  • Electrocardiography
  • Female
  • Heart Diseases (drug therapy, parasitology, physiopathology)
  • Humans
  • Male
  • Melarsoprol (therapeutic use)
  • Trypanocidal Agents (therapeutic use)
  • Trypanosoma brucei gambiense (pathogenicity)
  • Trypanosomiasis, African (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: